Potential of boron neutron capture therapy (BNCT) for myxofibrosarcoma

Appl Radiat Isot. 2024 Nov 26:217:111603. doi: 10.1016/j.apradiso.2024.111603. Online ahead of print.

Abstract

Myxofibrosarcoma, a rare malignant tumor, predominantly affects the extremities of the elderly. Because of its invasive nature amputation is sometimes required, resulting in serious deterioration of quality of life. Therefore, cell lines established from amputated surgical specimens of myxofibrosarcoma in the upper limbs of elderly patients were used to create a myxofibrosarcoma-bearing animal model and to investigate the therapeutic effect of BNCT thereon. The results demonstrated selective destruction of tumor cells, suggesting the anti-tumor efficacy of BNCT on myxofibrosarcoma.

Keywords: Boron neutron capture therapy (BNCT); Cell line; Myxofibrosarcoma; p-borono-(L)-phenylalanine ((L)-BPA).